Compelo Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More

FDA approves Hologic’s new C-View 2D imaging software

The US Food and Drug Administration (FDA) has approved the use of diagnostics provider Hologic's new C-View 2D imaging software.

C-View 2D images can now be used in place of the conventional 2D exposure previously required as part of a Hologic 3D mammography screening exam.

Studies have shown that screening with Hologic’s 3D mammography technology using C-View imaging provides better clinical results than that of a conventional 2D mammogram.

Hologic Breast Health senior vice president and general manager Peter Soltani said that the approval of C-View software is an important evolution in the company’s 3D mammography screening program.

"C-View software was developed to provide yet another option to imaging centers to improve patient care and clinical outcomes," Soltani added.